ARCHIVES

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

ACD Honors Sullivan, Who Reaffirms Anti-Smoking Effort

June 29, 1990

House Appropriations Adds $20 Mil. To Bush Request For NCI, Emphasizes Three Cancers

June 28, 1991

DCT Board Okays Six Contract Recompetitions

October 23, 1987

DeVita On Problems Of Drug Response: There May be Tw Populations Of Cells; Molecular Medicine will Change Treatment

December 13, 1991

Adamson Elected Chairman Of Children’s Oncology Group

December 11, 2009

Preyer Supported For Chairmanship

January 26, 1979